Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leo Hansmann

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|July 18, 2020
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphomaLorenz Thurner, Sylvia Hartmann, Moritz Bewarder, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Journal of Hematopathology|August 12, 2009
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL NetworkWolfram Klapper, Eva Hoster, Olaf Determann, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|July 18, 2020
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphomaLorenz Thurner, Sylvia Hartmann, Moritz Bewarder, et al.
Leukemia|August 10, 2023
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease formsSabrina Kalmbach, Michael Grau, Myroslav Zapukhlyak, et al.
Genes, Chromosomes & Cancer|October 2, 2008
Microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression statusCarsten Schwaenen, Andreas Viardot, Hilmar Berger, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Frontiers in Immunology|November 15, 2023
Prevention of CMV/EBV reactivation by double-specific T cells in patients after allogeneic stem cell transplantation: results from the randomized phase I/IIa MULTIVIR-01 studyArmin Gerbitz, Regina Gary, Michael Aigner, et al.
Journal of Hematopathology|August 12, 2009
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL NetworkWolfram Klapper, Eva Hoster, Olaf Determann, et al.
Leukemia|November 7, 2019
ATM activity in T cells is critical for immune surveillance of lymphoma in vivoArina Riabinska, Daria Lehrmann, Ron Daniel Jachimowicz, et al.
Blood Cancer Journal|August 26, 2025
Optimization and validation of the international metabolic prognostic index for CD19 CAR-T in large B-cell lymphomaMichael Winkelmann, Sandeep S Raj, Michael D Jain, et al.
Pageof 26